BroadOak Capital Partners
Overview
BroadOak Capital Partners is a privately held investment bank with a comprehensive focus on the life sciences industry. We offer advisory services including mergers and acquisitions, divestitures, business combinations, joint ventures, valuations and fairness opinions. We also engage in principal investment activities, including co-investments, as particularly compelling opportunities arise. Our sector focus includes research tools and consumables, diagnostics, therapeutics, healthcare IT, pharmaceutical services and medical devices.\\BroadOak provides multinational corporations, middle-market and entrepreneurial clients with the customized attention of a boutique while delivering a range of expertise more typically associated with a larger firm. Our industry focus allows the firm's principals to target their investment banking experience and insight to specific client needs.
Investment Focus
- Commercial-stage companies with proven market need for the company’s products or services
- Financial profile: Invest in commercial-stage companies from initial revenue through profitability
- Industry: Life sciences tools, services, and biopharma services
Portfolio Companies
Reach BroadOak Capital Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BroadOak Capital Partners
What sectors does BroadOak Capital Partners invest in?
BroadOak Capital Partners invests in Healthcare, Life Sciences, Medical Devices, Diagnostics, Biotechnology and Oncology, and is based in Bethesda, Maryland, United States. BroadOak Capital Partners is listed as a private equity in the ConnectSafely investor database.
What stage does BroadOak Capital Partners invest at?
BroadOak Capital Partners backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does BroadOak Capital Partners invest in?
BroadOak Capital Partners invests across United States.
Who are the partners at BroadOak Capital Partners?
Team members listed for BroadOak Capital Partners include Calvin Aubrey (Vice President) and Michael Caspani (Managing Director).
What companies has BroadOak Capital Partners invested in?
BroadOak Capital Partners's portfolio includes VIDA, Azure Biosystems, Harvard Bioscience, Axol, EpiCypher, IC Biomedical, Hudson Lab Automation and Pluristyx.
How do I contact BroadOak Capital Partners?
BroadOak Capital Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
